Connect Biopharma Holdings Limited Ordinary Shares CNTB
$2.55
+0.39%
at last close
Recent SEC Filings
| Form | Description | Filed | Document |
|---|---|---|---|
| 10-Q | 10-Q | 2026-08-12 | View → |
| 8-K | 8-K | 2026-08-12 | View → |
| 4 | FORM 4 | 2026-07-01 | View → |
| 4 | FORM 4 | 2026-07-01 | View → |
| 4 | 4 | 2026-06-02 | View → |
| 10-Q | 10-Q | 2026-05-12 | View → |
| 8-K | 8-K | 2026-05-12 | View → |
| 8-K | 8-K | 2026-04-23 | View → |
| 4 | FORM 4 | 2026-04-02 | View → |
| 4 | FORM 4 | 2026-04-02 | View → |
| 4 | 4 | 2026-04-01 | View → |
| 10-K | 10-K | 2026-03-31 | View → |
| 8-K | 8-K | 2026-03-31 | View → |
| 8-K | 8-K | 2026-03-30 | View → |
| 8-K | 8-K | 2025-12-23 | View → |
| 10-Q | 10-Q | 2025-11-12 | View → |
| 8-K | 8-K | 2025-11-12 | View → |
| 8-K | 8-K | 2025-09-16 | View → |
| 10-Q | 10-Q | 2025-08-13 | View → |
| 8-K | 8-K | 2025-08-13 | View → |
| 8-K | 8-K | 2025-07-22 | View → |
| 8-K | 8-K | 2025-07-21 | View → |
| 8-K | 8-K | 2025-07-17 | View → |
| 8-K | 8-K | 2025-07-09 | View → |
| 10-Q | 10-Q | 2025-05-15 | View → |
| 8-K | 8-K | 2025-05-15 | View → |
| 8-K | 8-K | 2025-05-14 | View → |
| 8-K | 8-K | 2025-05-13 | View → |
| 8-K | 8-K | 2025-04-01 | View → |
| 10-K | 10-K | 2025-03-31 | View → |
| 8-K | 8-K | 2025-03-31 | View → |
| 6-K | 6-K | 2025-03-28 | View → |
| 6-K | 6-K | 2024-12-23 | View → |
| 6-K | 6-K | 2024-09-06 | View → |
| 6-K | 6-K | 2024-09-05 | View → |
| 6-K | 6-K | 2024-08-02 | View → |
| 6-K | 6-K | 2024-06-12 | View → |
| 20-F | 20-F | 2024-04-16 | View → |
| 6-K | 6-K | 2024-04-16 | View → |
| SC 13D | SC 13D | 2024-02-13 | View → |
Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.
Key Stats
- Last Close
- $2.55
- Market Cap
- $146.71 million
- 52-Week Range
- $1.09 – $3.82
- Average Volume
- 466K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.
